ApproachCell therapy

TCR-engineered T cells

Approach Europe PMC, retrieved 14 November 2026Inferred from the records, not an official entity

Kind: Approach
Topic: Cell therapy
What it covers: T cells given a T-cell receptor against a tumor antigen (mutant KRAS, TP53, neoantigens); works only in patients with the matching HLA type